These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 9489527)

  • 61. Longitudinal EEG changes correlate with cognitive measure deterioration in Parkinson's disease.
    Caviness JN; Hentz JG; Belden CM; Shill HA; Driver-Dunckley ED; Sabbagh MN; Powell JJ; Adler CH
    J Parkinsons Dis; 2015; 5(1):117-24. PubMed ID: 25420672
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Instrumental activities of daily living in Parkinson's disease dementia as compared with Alzheimer's disease: relationship to motor disability and cognitive deficits: a pilot study.
    Rasovska H; Rektorova I
    J Neurol Sci; 2011 Nov; 310(1-2):279-82. PubMed ID: 21851954
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients.
    Pellecchia MT; Santangelo G; Picillo M; Pivonello R; Longo K; Pivonello C; Vitale C; Amboni M; De Rosa A; Moccia M; Erro R; De Michele G; Santoro L; Colao A; Barone P
    J Neurol; 2013 Feb; 260(2):438-44. PubMed ID: 22911513
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The influence of vascular risk factors on cognitive function in early Parkinson's disease.
    Doiron M; Langlois M; Dupré N; Simard M
    Int J Geriatr Psychiatry; 2018 Feb; 33(2):288-297. PubMed ID: 28509343
    [TBL] [Abstract][Full Text] [Related]  

  • 65. PDD-Short Screen: a brief cognitive test for screening dementia in Parkinson's disease.
    Pagonabarraga J; Kulisevsky J; Llebaria G; García-Sánchez C; Pascual-Sedano B; Martinez-Corral M; Gironell A
    Mov Disord; 2010 Mar; 25(4):440-6. PubMed ID: 20155863
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Addenbrooke's Cognitive Examination validation in Parkinson's disease.
    Reyes MA; Perez-Lloret S; Roldan Gerschcovich E; Martin ME; Leiguarda R; Merello M
    Eur J Neurol; 2009 Jan; 16(1):142-7. PubMed ID: 19049504
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment.
    Kulisevsky J; Pagonabarraga J
    Mov Disord; 2009 Jun; 24(8):1103-10. PubMed ID: 19353727
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Electroencephalographic prodromal markers of dementia across conscious states in Parkinson's disease.
    Latreille V; Carrier J; Gaudet-Fex B; Rodrigues-Brazète J; Panisset M; Chouinard S; Postuma RB; Gagnon JF
    Brain; 2016 Apr; 139(Pt 4):1189-99. PubMed ID: 26912643
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Is fatigue associated with cognitive dysfunction in early Parkinson's disease?
    Kluger BM; Pedersen KF; Tysnes OB; Ongre SO; Øygarden B; Herlofson K
    Parkinsonism Relat Disord; 2017 Apr; 37():87-91. PubMed ID: 28202373
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Regional cerebral blood flow in Parkinson's disease as an indicator of cognitive impairment.
    Derejko M; Sławek J; Wieczorek D; Brockhuis B; Dubaniewicz M; Lass P
    Nucl Med Commun; 2006 Dec; 27(12):945-51. PubMed ID: 17088679
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia.
    Camicioli R; Sabino J; Gee M; Bouchard T; Fisher N; Hanstock C; Emery D; Martin WR
    Mov Disord; 2011 Jul; 26(8):1443-50. PubMed ID: 21442661
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Picture and motor sequencing in Parkinson's disease.
    Beatty WW; Monson N
    J Geriatr Psychiatry Neurol; 1990; 3(4):192-7. PubMed ID: 2073306
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Preclinical syndromes predict dementia: the Sydney older persons study.
    Waite LM; Broe GA; Grayson DA; Creasey H
    J Neurol Neurosurg Psychiatry; 2001 Sep; 71(3):296-302. PubMed ID: 11511700
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Influence of depression in mild Parkinson's disease on longitudinal motor and cognitive function.
    Ng A; Chander RJ; Tan LC; Kandiah N
    Parkinsonism Relat Disord; 2015 Sep; 21(9):1056-60. PubMed ID: 26117438
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A neuropsychological comparison of demented and nondemented patients with Parkinson's disease.
    Zakzanis KK; Freedman M
    Appl Neuropsychol; 1999; 6(3):129-46. PubMed ID: 10497689
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Extended "Timed Up and Go" assessment as a clinical indicator of cognitive state in Parkinson's disease.
    Evans T; Jefferson A; Byrnes M; Walters S; Ghosh S; Mastaglia FL; Power B; Anderton RS
    J Neurol Sci; 2017 Apr; 375():86-91. PubMed ID: 28320196
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Neuropsychological differences between the dementias of Alzheimer's and Parkinson's diseases.
    Huber SJ; Shuttleworth EC; Freidenberg DL
    Arch Neurol; 1989 Dec; 46(12):1287-91. PubMed ID: 2590012
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The impact of silent vascular brain burden in cognitive impairment in Parkinson's disease.
    González-Redondo R; Toledo J; Clavero P; Lamet I; García-García D; García-Eulate R; Martínez-Lage P; Rodríguez-Oroz MC
    Eur J Neurol; 2012 Aug; 19(8):1100-7. PubMed ID: 22360775
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Cognitive deterioration in Parkinson's disease].
    Vilert Barnet J; Jarne Esparcia A; Aguilar Barbera M
    Arch Neurobiol (Madr); 1991; 54(6):311-7. PubMed ID: 1811462
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Behavioural assessment of dysexecutive syndrome in Parkinson's disease without dementia: a comparison with other clinical executive tasks.
    Perfetti B; Varanese S; Mercuri P; Mancino E; Saggino A; Onofrj M
    Parkinsonism Relat Disord; 2010 Jan; 16(1):46-50. PubMed ID: 19665420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.